GlassScriptPhysician profile
Jamal Sahyouni
NPI 1649261090
$4,496.86
in general payments reported to CMS, 2019-2025
26 companies · $698 in 2025
The $698 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $320 · 2021: $305 · 2022: $1,645 · 2023: $603 · 2024: $740 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,040.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,767.03 | 2021-2025 | |
| Organogenesis INC. | $994.67 | 2019-2025 | Puraply, Cygnus Matrix, Cygnus Dual |
| Lilly USA, LLC | $690.90 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Xeris Pharmaceuticals, INC. | $182.75 | 2023-2025 | Gvoke Hypopen |
| Smith+Nephew, INC. | $107.65 | 2019-2025 | Grafix Pl, Renasys Touch, Oasis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.31 | 2019-2025 | Jardiance |
| Abbott Laboratories | $75.86 | 2022-2025 | Freestyle Libre 3 |
| Insulet Corporation | $66.08 | 2024-2025 | Omnipod |
| Dexcom, INC. | $52.57 | 2021-2024 | Dexcom G6 Transmitter |
| Solventum Corporation | $49.52 | 2024-2025 | Activ.A.C., 3m Coban, Promogran Prisma |
| Tandem Diabetes Care, INC. | $47.57 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $42.77 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $41.59 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $39.32 | 2020-2024 | Farxiga |
| Kerecis Limited | $36.97 | 2021-2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $36.62 | 2021-2023 | Promogran Prisma, Activ.A.C., V.A.C. Dermatac |
| Merck Sharp & Dohme LLC | $24.14 | 2019 | |
| Advanced Oxygen Therapy INC. | $20.38 | 2025 | Topical Oxygen Chamber For Extremities |
| Esperion Therapeutics, INC. | $20.16 | 2025 | Nexletol |
| Cashflow Solutions, LLC | $17.90 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Ultragenyx Pharmaceutical INC. | $15.15 | 2022 | |
| Medtronic, INC. | $14.77 | 2024 | Minimed 780g |
| Integra Lifesciences Corporation | $14.61 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.51 | 2023 | Nuzyra |
| Reprise Biomedical, INC. | $14.18 | 2025 | Miro3d |
| Hartmann USA, INC. | $13.88 | 2024 | Zetuvit Plus 10x10 P10 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamal Sahyouni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.